CLINICAL SCIENCE

Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye

Pasquale Aragona¹, Vincenzo Papa³, Antonio Micali², Marcello Santocono³ and Giovanni Milazzo³

¹ Institute of Ophthalmology, University of Messina, Italy
² Department of Biomorphology, University of Messina, Italy
³ Clinical Department SIFI SpA, Lavinaio-Catania, Italy

Correspondence to:
Correspondence to:
Dr Giovanni Milazzo, SIFI SpA, Clinical Research Department, Via Ercole Patti, 36, Lavinaio (CT)-95020, Italy;
giovanni_milazzo{at}sifi.it

Background/aims: Several studies have reported that sodium hyaluronate is able to improve both symptoms and signs in patients with dry eye but none have demonstrated an improvement of conjunctival epithelial cell abnormalities of the ocular surface. The aim of this study was to explore the effect of sodium hyaluronate-containing eye drops on the ocular surface of patients with dry eye during long term treatment.

Methods: A randomised double blind study was undertaken in 86 patients with medium to severe dry eye (that is, rose bengal and/or fluorescein test score of at least 3, tear film break up time <10 seconds, or Schirmer's test <5.5 mm). Patients were treated with either preservative-free sodium hyaluronate or saline for 3 months at a dose of one drop 4–8 times a day. Bulbar impression cytology, slit lamp examinations, and subjective symptoms were evaluated after 1, 2, and 3 months. Impression cytology was considered the primary efficacy parameter of the study.

Results: The efficacy analysis was performed on a total of 44 patients who were able to fully adhere to the protocol. After 3 months of treatment sodium hyaluronate improved impression cytology score (p = 0.024 v baseline). At the same time also the difference with respect to placebo was statistically significant (p = 0.036). Study medication was well tolerated and no treatment related adverse events occurred during the study.

Conclusions: Sodium hyaluronate may effectively improve ocular surface damage associated with dry eye syndrome.

Keywords: hyaluronic acid; dry eye; impression cytology

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Mochizuki, H, Yamada, M, Hato, S, Nishida, T (2008). Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid. Br. J. Ophthalmol. 92: 108-111 [Abstract] [Full Text]  
• Oh, J. Y., In, Y. S., Kim, M. K., Ko, J. H., Lee, H. J., Shin, K. C., Lee, S. M., Wee, W. R., Lee, J. H., Park, M. (2007). Protective Effect of Uridine on Cornea in a Rabbit Dry Eye Model. IOVS 48: 1102-1109 [Abstract] [Full Text]  
• Prabhasawat, P, Tesavibul, N, Kasetsuwan, N (2007). Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study. Br. J. Ophthalmol. 91: 47-50 [Abstract] [Full Text]  
• Gomes, J A P, Amankwah, R, Powell-Richards, A, Dua, H S (2004). Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br. J. Ophthalmol. 88: 821-825 [Abstract] [Full Text]  
• Horwath-Winter, J., Berghold, A., Schmut, O., Floegel, I., Solhdju, V., Bodner, E., Schwantzer, G., Haller-Schober, E.-M. (2003). Evaluation of the Clinical Course of Dry Eye Syndrome. Arch Ophthalmol 121: 1364-1368 [Abstract] [Full Text]  
• Aragona, P, Di Stefano, G, Ferreri, F, Spinella, R, Stilo, A (2002). Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients. Br. J. Ophthalmol. 86: 879-884 [Abstract] [Full Text]